Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kalil Saab
Institution:
Baylor College of Medicine
Observed institution:
Baylor College of Medicine
ORCID:
0009-0005-2066-2700
Observed ORCID:
0009-0005-2066-2700
OpenAlex ID:
A5119137653
Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025
·
Rutulkumar Patel
, Kalil Saab
, et al.
·
Clinical Cancer Research
·
17
Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer through effective PI3Kinase targeting
2025
·
Pedram Yadollahi
, Kelli A. McCord
, et al.
·
British Journal of Cancer
·
2
PDF
PI3Kinase based degradation of NRF2 signaling in chemo-radiation resistant HNSCC
2026
·
Pedram Yadollahi
, Yang Li
, et al.
·
Research Square
PDF
Supplementary figure 6 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025
·
Rutulkumar Patel
, Kalil Saab
, et al.
PDF
Supplementary figure 5 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025
·
Rutulkumar Patel
, Kalil Saab
, et al.
Supplementary Table 1 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025
·
Rutulkumar Patel
, Kalil Saab
, et al.
Supplementary figure 7 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025
·
Rutulkumar Patel
, Kalil Saab
, et al.
Supplementary Table 2 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025
·
Rutulkumar Patel
, Kalil Saab
, et al.
Supplementary figure 1 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025
·
Rutulkumar Patel
, Kalil Saab
, et al.
Supplementary figure 4 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025
·
Rutulkumar Patel
, Kalil Saab
, et al.
PDF
Supplementary Materials & Methods1 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025
·
Rutulkumar Patel
, Kalil Saab
, et al.
Supplementary figure 3 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025
·
Rutulkumar Patel
, Kalil Saab
, et al.
Supplementary figure 2 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025
·
Rutulkumar Patel
, Kalil Saab
, et al.
Data from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025
·
Rutulkumar Patel
, Kalil Saab
, et al.
Show more works
View as search
Works count:
14
Citation count:
19
H-index:
2
I10-index:
1
Year
Topic
Type